Michael J. Running Sells 1,250 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) insider Michael J. Running sold 1,250 shares of the firm’s stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $138.62, for a total value of $173,275.00. Following the transaction, the insider now directly owns 1,276 shares in the company, valued at $176,879.12. This trade represents a 49.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Plexus Stock Down 1.4 %

NASDAQ PLXS opened at $134.31 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The stock has a market capitalization of $3.63 billion, a PE ratio of 31.16 and a beta of 0.89. Plexus Corp. has a 1 year low of $90.18 and a 1 year high of $172.89. The business’s 50-day moving average is $151.94 and its 200 day moving average is $145.48.

Plexus (NASDAQ:PLXSGet Free Report) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Sell-side analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.

Institutional Trading of Plexus

Large investors have recently modified their holdings of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Plexus by 17.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 70,506 shares of the technology company’s stock worth $11,033,000 after buying an additional 10,717 shares during the period. Squarepoint Ops LLC lifted its holdings in Plexus by 1.1% in the fourth quarter. Squarepoint Ops LLC now owns 13,846 shares of the technology company’s stock worth $2,167,000 after buying an additional 148 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in Plexus in the fourth quarter worth about $391,000. Sig Brokerage LP purchased a new stake in Plexus in the fourth quarter worth about $573,000. Finally, Point72 Asia Singapore Pte. Ltd. lifted its holdings in Plexus by 140.7% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 975 shares of the technology company’s stock worth $153,000 after buying an additional 570 shares during the period. 94.45% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PLXS has been the topic of a number of recent research reports. Needham & Company LLC raised their price objective on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Stifel Nicolaus initiated coverage on Plexus in a research note on Tuesday, February 4th. They set a “hold” rating and a $152.00 price objective on the stock. Benchmark reaffirmed a “buy” rating and set a $165.00 price objective on shares of Plexus in a research note on Wednesday, January 22nd. Finally, StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $163.00.

Read Our Latest Analysis on PLXS

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.